MBA
EXC icon

Maple-Brown Abbott’s Exelon EXC Stock Holding History

Maple-Brown Abbott’s Portfolio EXC Stock Details EXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$145M Buy
3,154,588
+846,358
+37% +$35.4M 9.91% 2
2024
Q4 		$86.9M Sell
2,308,230
-23,480
-1% -$911K 10.6% 2
2024
Q3 		$94.5M Sell
2,331,710
-21,600
-0.9% -$812K 9.37% 5
2024
Q2 		$81.5M Buy
2,353,310
+64,760
+3% +$2.39M 8.59% 6
2024
Q1 		$86M Sell
2,288,550
-61,030
-3% -$2.18M 8.79% 8
2023
Q4 		$84.3M Buy
2,349,580
+646,710
+38% +$24.9M 8.59% 7
2023
Q3 		$64.4M Buy
+1,702,870
New +$69.4M 7.38% 7

Other funds holding EXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Maple-Brown Abbott's EXC Position: Q1 2025 in Review

Maple-Brown Abbott increased its Exelon (EXC) stake by 37% in Q1 2025, buying an estimated $35.4M and bringing the position to 3,154,588 shares worth $145M. The position accounts for 9.91% of the portfolio, ranked #2.

Maple-Brown Abbott first reported a position in EXC in Q3 2023 and has held it in 7 quarters since. 1,194 funds tracked by Wall St. Rank hold EXC as of Q1 2025.

  • Maple-Brown Abbott held 3,154,588 shares of Exelon worth $145M as of Q1 2025.
  • Maple-Brown Abbott bought 846,358 Exelon shares in Q1 2025, an estimated $35.4M.
  • Exelon made up 9.91% of Maple-Brown Abbott's portfolio in Q1 2025, its #2 holding.
  • Maple-Brown Abbott first reported a position in Exelon in Q3 2023 and has held it in 7 quarters since.
  • 1,194 funds tracked by Wall St. Rank held Exelon as of Q1 2025.

Based on Maple-Brown Abbott's 13F filing for Q1 2025, filed 13 May 2025.